Merck & Co to buy Avecia Biologics
US drug major Merck & Co will buy into the UK's contract biologics manufacturing sector with the acquisition of Tees Valley-based Avecia Biologics.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs